Jingwei Yao Selected Research

Jingwei Yao Research Topics

8	Neoplasms (Cancer) 01/2024 - 06/2021
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 07/2023
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 12/2022
2	Leukemia 12/2023 - 11/2022
1	Bites and Stings (Sting) 01/2024
1	Lymphoma (Lymphomas) 08/2023
1	Hypopharyngeal Neoplasms 01/2023
1	Carcinogenesis 12/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022
1	COVID-19 03/2022
1	Laryngeal Neoplasms (Laryngeal Cancer) 02/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2020

2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2022
2	anlotinibIBA 01/2024 - 11/2022
2	NucleotidesIBA 01/2023 - 01/2022
1	Simvastatin (Zocor)FDA LinkGeneric 12/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023
1	Interferon Regulatory FactorsIBA 12/2023
1	p38 Mitogen-Activated Protein KinasesIBA 08/2023
1	orelabrutinibIBA 08/2023
1	FITC-annexin A5IBA 08/2023
1	venetoclaxIBA 08/2023
1	Phospholipase DIBA 07/2023
1	RitanserinIBA 07/2023
1	Proteins (Proteins, Gene)FDA Link 12/2022
1	chiauranibIBA 12/2022
1	NanovaccinesIBA 03/2022
1	Therapeutic UsesIBA 02/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	ElementsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	AntigensIBA 06/2021
1	EpitopesIBA 06/2021
1	Tamoxifen FDA LinkGeneric 01/2020

4	Therapeutics 01/2023 - 06/2021
1	Radiotherapy 02/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2022
1	Immunotherapy 06/2021